SCSikuli Capital Unusual Machines UMAC · Valuation Snapshot · May 2026
Download PDF
SIKULI CAPITAL · INVESTMENT RESEARCH

Unusual Machines

UMAC
Valuation Snapshot — Fair Value Range
As of May 2026
CURRENT PRICE PROBABILITY-WEIGHTED FAIR VALUE FAIR VALUE RANGE
$13.66 ~$15 $7 – $25
May 2026 Bull 25% / Base 50% / Bear 25% Speculative; defense drone tailwind

Verdict: UMAC delivered Q1 2026 revenue of $8.1M (+296% YoY) and net income of $10.3M (aided by $16.8M of investment gains)[1]. The company raised ~$150M at $17/share, ending Q1 with $223M in cash and announcing the $52M DroneNX acquisition. As a small-cap pure-play on NDAA-compliant drone components, UMAC has tailwinds from US defense / Section 889 enforcement. Needham PT is $22. Margin pressure persists — Q1 operating result was loss-making excluding investment gains[2]. Bull case requires consolidation thesis to deliver scale; bear case reflects competition from Skydio and integrated drone makers.

CURRENT SNAPSHOT

Metric Value Notes / Source
Stock price $13.66 [3]
Q1 2026 revenue $8.1M (+296%) Sequential +65% [1]
Q1 2026 net income $10.3M Aided by $16.8M investment gains [1]
Cash $222.9M Post $150M raise at $17 [1]
DroneNX acquisition $52M Drone components consolidation [1]
Needham PT $22 [3]

BULL / BASE / BEAR SCENARIOS

Scenario (weight) Assumptions Fair Value
Bull (25%) Defense drone consolidation thesis works, NDAA enforcement accelerates, scales to $50M+ run-rate $25
Base (50%) Modest revenue growth, M&A integration, market cap ~ Needham PT $15
Bear (25%) Drone competition heats up, margin compression, M&A doesn't drive scale $7
Probability-weighted Speculative small-cap defense play; binary execution risk. ~$15

Key Risks

What Would Change Our View

Sources

[1] https://www.stocktitan.net/news/UMAC/unusual-machines-first-quarter-2026-shareholder-qweyz30siac6.html

[2] https://simplywall.st/stocks/us/tech/nysemkt-umac/unusual-machines/news/unusual-machines-umac-margin-pressure-persists-as-loss-per-s

[3] https://finance.yahoo.com/quote/UMAC/

Disclaimer

This output is for informational and research-assistance purposes only. It does not constitute investment, legal, tax, accounting, or other professional advice, and it is not a recommendation to buy, sell, or hold any security. Verify material facts independently and consult qualified advisors before making decisions.